Adalo, the visual app builder used by over 300,000 makers worldwide, today announced Adalo Blue, an on-premise enterprise platform featuring the AnyData API Plane -- a governed data layer that ...

Why Passwords Are Still a Developer's Problem in 2026. The case against password-based authentication is well-established in the IAM community, but the practical implications for ...

But Google is public that two other programs, Apps Experience and Games Level Up, will let developers save up to 5 percent more of their hard-earned cash — if they make games an ...

South Africa’s National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic ...

South Africa's National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country.

Amazon won a temporary court order blocking Perplexity’s Comet AI agent from making purchases on its site. The judge ruled that Amazon provided evidence of unauthorized access to password-protected ...

Google has earned a reputation for removing popular Android features, while often not adequately replacing them, and here's five that met the chopping block.

Aspire Biopharma’s new sublingual powder bypasses digestion, delivering alprazolam directly for faster anxiety and panic ...

Forma Life Sciences, which inherited BioDuro’s California production operations earlier this year, has officially ...

Great. Good morning, everyone. Thanks for joining us here at day 2 of the Leerink Partners Global Healthcare Conference. My name is Tom Smith. I'm one of the senior biotech analysts here at Leerink.